The Health Resources and Services Administration (HRSA) has updated its guidelines to include self-collection testing for cervical cancer screening for women aged 30-65 with average risk. Cervical ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara and Novo Nordisk’s Novolog. The Trump administration announced in August ...

The Invesco RAFI US 1000 ETF uses a fundamentally weighted, rules-based approach, offering diversification and a value tilt with a balanced growth exposure versus traditional cap-weighted ETFs. The ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

On June 13, 2025, OIG announced the results of an audit it conducted of 30 hospitals that received provider relief fund (PRF) payments during COVID-19 (the Audit). OIG found that 11 of the 30 audited ...

A new audit of nursing homes that received emergency federal funding to stay in business during the pandemic found that one-third misspent a small share of their Provider Relief allotments or failed ...

The restructuring plans announced by HHS last week included folding five offices into one entity: the Substance Abuse and Mental Health Services Administration (SAMHSA), the Health Resources and ...

Thomas Engels has been named administrator of the Health Resources and Services Administration. Mr. Engels returns to the role after previously serving as administrator from 2019 to 2021. He also ...

Sanofi filed a lawsuit against the Health Resources and Services Administration in federal court Dec. 16, challenging the agency’s decision to potentially remove the company from the 340B Drug Pricing ...

Drugmakers say they’re trying to crack down on abuse in the 340B program, which was established more than three decades ago in order to make it easier for hospitals serving more vulnerable populations ...

This past September, a sub-agency of the Department of Health and Human Services (HHS) threatened to kick a pharmaceutical company out of Medicare because the company, in line with federal law, ...